nach oben

Lasers in Medical Science

Erschienen in:

28.09.2021 | Review Article

A systematic review and meta-analysis of fluorescent-guided resection and therapy-based photodynamics on the survival of patients with glioma

verfasst von: Zhongyu Ren, Jun Wen, Yunyan Mo, Peng Zhang, Hanren Chen, Jian Wen

Erschienen in: Lasers in Medical Science | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Glioma is the most common primary central nervous system tumor; many methods are currently being used to research and treat glioma. In recent years, fluorescent-guided resection (FGR) and photodynamic therapy (PDT) have become hot spots in the treatment of glioma. Based on the existing literatures regarding the FGR enhancing resection rate and regarding efficacy of PDT for the treatment of glioma, this paper made a systematic review of FGR for gross total resection of patients and the PDT for the survival of patients with glioma. Meta-analysis of eligible studies was performed to derive precise estimation of PDT on the prognosis of patients with glioma by searching all related literatures in PubMed, EMBASE, Cochrane, and Web of Science databases, and further to evaluate (GTR) under FGR and the efficacy of PDT therapy, including 1-year and 2-year survival rates, overall survival (OS), and progression-free survival (PFS). According to the inclusion and exclusion criteria, a total of 1294 patients with glioma were included in the final analysis of 31 articles, among which a 73.00% (95% CI, 68.00 ~ 79.00%, P < 0.01) rate of GTR in 27 groups included in 23 articles was reported for those receiving FGR. The OS was 17.78 months (95% CI, 8.89 ~ 26.67, P < 0.01) in 5 articles on PDT-treated patients with glioma, and the mean difference of OS was 6.18 (95% CI, 3.3 ~ 9.06, P < 0.01) between PDT treatment and conventional glioma surgery, showing a statistically significant difference (P < 0.01). The PFS was 10.82 months (95% CI, 7.04 ~ 14.61, P < 0.01) in 5 articles on PDT-treated patients with glioma. A 1-year survival rate of 59.00% (95% CI, 38.00 ~ 77.00%, P < 0.01) in 10 groups included in 8 articles and 2-year survival rate of 25.00% (95% CI, 15.00 ~ 36.00%, P < 0.01) in 7 groups included in 6 articles were reported for those with PDT. FGR and PDT are feasible for treatment of patients with glioma, because FGR can effectively increase the resection rate, at the same time, PDT can prolong the survival time. However, due to the limitation of small sample size in the existing studies, larger samples and randomized controlled clinical trials are needed to analyze the resection under FGR and efficacy of PDT in patients with glioma.

Stupp R, Roila F (2009) Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 20(Suppl 4):126–128PubMedCrossRef

Reifenberger G, Wirsching HG, Knobbe-Thomsen CB et al (2017) Advances in the molecular genetics of —implications for classification and therapy. Nat Rev Clin Oncol 14(7):434–452PubMedCrossRef

Shergalis A, Bankhead A 3rd, Luesakul U et al (2018) Current challenges and opportunities in treating glioblastoma. Pharmacol Rev 70(3):412–445PubMedPubMedCentralCrossRef

Haj A, Doenitz C, Schebesch KM et al (2017) Extent of resection in newly diagnosed glioblastoma: impact of a specialized neuro-oncology care center. Brain Sci 8(1):5PubMedCentralCrossRef

Sanai N, Polley MY, McDermott MW et al (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115(1):3–8PubMedCrossRef

Hu L, Lv QL, Chen SH et al (2016) Up-regulation of long non-coding RNA AB073614 predicts a poor prognosis in patients with glioma. Int J Environ Res Public Health 13(4):433PubMedPubMedCentralCrossRef

Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95(2):190–198PubMedCrossRef

Obwegeser A, Ortler M, Seiwald M et al (1995) Therapy of glioblastoma multiforme: a cumulative experience of 10 years. Acta Neurochir (Wien) 137(1–2):29–33CrossRef

Mitton D, Ackroyd R (2008) A brief overview of photodynamic therapy in Europe. Photodiagnosis Photodyn Ther 5(2):103–111PubMedCrossRef

10.

Pichlmeier U, Bink A, Schackert G et al (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10(6):1025–1034PubMedPubMedCentralCrossRef

11.

Brown TJ, Brennan MC, Li M et al (2016) Association of the extent of resection with survival in glioblastoma: a systematic review and meta-analysis. JAMA Oncol 2(11):1460–1469PubMedPubMedCentralCrossRef

12.

Dougherty TJ, Gomer CJ, Henderson BW et al (1998) Photodynamic therapy. J Natl Cancer Inst 90(12):889–905PubMedCrossRef

13.

Juarranz Á, Gilaberte Y, González S (2020) Photodynamic therapy (PDT) in oncology. Cancers (Basel) 12(11):3341CrossRef

14.

McGirt MJ, Chaichana KL, Gathinji M et al (2009) Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 110(1):156–162PubMedCrossRef

15.

Kostron H, Obwegeser A, Jakober R (1996) Photodynamic therapy in neurosurgery: a review. J Photochem Photobiol B 36(2):157–168PubMedCrossRef

16.

Castano AP, Demidova TN, Hamblin MR (2004) Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. Photodiagnosis Photodyn Ther 1(4):279–293PubMedPubMedCentralCrossRef

17.

Seshadri M, Bellnier DA, Vaughan LA et al (2008) Light delivery over extended time periods enhances the effectiveness of photodynamic therapy. Clin Cancer Res 14(9):2796–2805PubMedPubMedCentralCrossRef

18.

Angell-Petersen E, Spetalen S, Madsen SJ et al (2006) Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model. J Neurosurg 104(1):109–117PubMedCrossRef

19.

Muller PJ, Wilson BC (2006) Photodynamic therapy of brain tumors—a work in progress. Lasers Surg Med 38(5):384–389PubMedCrossRef

20.

Mazurek M, Kulesza B, Stoma F et al (2020) Characteristics of fluorescent intraoperative dyes helpful in gross total resection of high-grade gliomas—a systematic review. Diagnostics (Basel) 10(12):1100CrossRef

21.

Eljamel S (2010) Photodynamic applications in brain tumors: a comprehensive review of the literature. Photodiagnosis Photodyn Ther 7(2):76–85PubMedCrossRef

22.

Stummer W, Novotny A, Stepp H et al (2000) Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 93(6):1003–1013PubMedCrossRef

23.

Kostron H, Fiegele T, Akatuna E (2006) Combination of FOSCAN® mediated fluorescence guided resection and photodynamic treatment as new therapeutic concept for malignant brain tumors. Med Laser Appl 21(4):285–290CrossRef

24.

Stummer W, Pichlmeier U, Meinel T et al (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7(5):392–401PubMedCrossRef

25.

Beck TJ, Kreth FW, Beyer W et al (2007) Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5-aminolevulinic acid induced protoporphyrin IX. Lasers Surg Med 39(5):386–393PubMedCrossRef

26.

Nabavi A, Thurm H, Zountsas B et al (2009) Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study. Neurosurgery 65(6):1070–1076 (discussion 1076 1077)PubMedCrossRef

27.

Feigl GC, Ritz R, Moraes M et al (2010) Resection of malignant brain tumors in eloquent cortical areas: a new multimodal approach combining 5-aminolevulinic acid and intraoperative monitoring. J Neurosurg 113(2):352–357PubMedCrossRef

28.

Díez Valle R, Tejada Solis S, Idoate Gastearena MA et al (2011) Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience. J Neurooncol 102(1):105–113PubMedCrossRef

29.

Idoate MA, Díez Valle R, Echeveste J et al (2011) Pathological characterization of the glioblastoma border as shown during surgery using 5-aminolevulinic acid-induced fluorescence. Neuropathology 31(6):575–582PubMedCrossRef

30.

Tsugu A, Ishizaka H, Mizokami Y et al (2011) Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma. World Neurosurg 76(1–2):120–127PubMedCrossRef

31.

Akimoto J, Haraoka J, Aizawa K (2012) Preliminary clinical report on safety and efficacy of photodynamic therapy using talaporfin sodium for malignant gliomas. Photodiagnosis Photodyn Ther 9(2):91–99PubMedCrossRef

32.

Cortnum S, Laursen RJ (2012) Fluorescence-guided resection of gliomas. Dan Med J 59(8):A4460PubMed

33.

Eyüpoglu IY, Hore N, Savaskan NE et al (2012) Improving the extent of malignant glioma resection by dual intraoperative visualization approach. PLoS One 7(9):e44885PubMedPubMedCentralCrossRef

34.

Roessler K, Becherer A, Donat M et al (2012) Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery. Neurol Res 34(3):314–317PubMedCrossRef

35.

Schucht P, Beck J, Abu-Isa J et al (2012) Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping. Neurosurgery 71(5):927–935 (discussion 935 926)PubMedCrossRef

36.

Tejada-Solís S, Aldave-Orzaiz G, Pay-Valverde E et al (2012) Prognostic value of ventricular wall fluorescence during 5-aminolevulinic-guided surgery for glioblastoma. Acta Neurochir (Wien) 154(11):1997–2002 (discussion 2002)CrossRef

37.

Della Puppa A, Ciccarino P, Lombardi G et al (2014) 5-Aminolevulinic acid fluorescence in high grade glioma surgery surgical outcome, intraoperative findings, and fluorescence patterns. Biomed Res Int 2014:232561PubMed

38.

Piquer J, Llácer JL, Rovira V et al (2014) Fluorescence-guided surgery and biopsy in gliomas with an exoscope system. Biomed Res Int 2014:207974PubMedPubMedCentralCrossRef

39.

Coburger J, Hagel V, Wirtz CR et al (2015) Surgery for glioblastoma: impact of the combined use of 5-aminolevulinic acid and intraoperative MRI on extent of resection and survival. PLoS One 10(6):e0131872PubMedPubMedCentralCrossRef

40.

Schatlo B, Fandino J, Smoll NR et al (2015) Outcomes after combined use of intraoperative MRI and 5-aminolevulinic acid in high-grade glioma surgery. Neuro Oncol 17(12):1560–1567PubMedPubMedCentralCrossRef

41.

Della Puppa A, Lombardi G, Rossetto M et al (2017) Outcome of patients affected by newly diagnosed glioblastoma undergoing surgery assisted by 5-aminolevulinic acid guided resection followed by BCNU wafers implantation: a 3-year follow-up. J Neurooncol 131(2):331–340PubMedCrossRef

42.

Chan DTM, Yi-Pin Sonia H, Poon WS (2018) 5-Aminolevulinic acid fluorescence guided resection of malignant glioma: Hong Kong experience. Asian J Surg 41(5):467–472PubMedCrossRef

43.

Akimoto J, Fukami S, Ichikawa M et al (2019) Intraoperative photodiagnosis for malignant glioma using photosensitizer talaporfin sodium. Front Surg 6:12PubMedPubMedCentralCrossRef

44.

Schipmann S, Müther M, Stögbauer L et al (2020) Combination of ALA-induced fluorescence-guided resection and intraoperative open photodynamic therapy for recurrent glioblastoma: case series on a promising dual strategy for local tumor control. J Neurosurg 24(1):11

45.

Rosenthal MA, Kavar B, Uren S et al (2003) Promising survival in patients with high-grade gliomas following therapy with a novel boronated porphyrin. J Clin Neurosci 10(4):425–427PubMedCrossRef

46.

Eljamel MS, Goodman C, Moseley H (2008) ALA and photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial. Lasers Med Sci 23(4):361–367PubMedCrossRef

47.

Muragaki Y, Akimoto J, Maruyama T et al (2013) Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. J Neurosurg 119(4):845–852PubMedCrossRef

48.

Nitta M, Muragaki Y, Maruyama T et al (2018) Role of photodynamic therapy using talaporfin sodium and a semiconductor laser in patients with newly diagnosed glioblastoma. J Neurosurg 7(1):8

49.

Muller PJ, Wilson BC (1995) Photodynamic therapy for recurrent supratentorial gliomas. Semin Surg Oncol 11(5):346–354PubMedCrossRef

50.

Muller PJ, Wilson BC (1996) Photodynamic therapy for malignant newly diagnosed supratentorial gliomas. J Clin Laser Med Surg 14(5):263–270PubMedCrossRef

51.

Stylli SS, Kaye AH, MacGregor L et al (2005) Photodynamic therapy of high grade glioma—long term survival. J Clin Neurosci 12(4):389–398PubMedCrossRef

52.

Gandhi S, TayebiMeybodi A, Belykh E et al (2019) Survival outcomes among patients with high-grade glioma treated with 5-aminolevulinic acid-guided surgery: a systematic review and meta-analysis. Front Oncol 9:620PubMedPubMedCentralCrossRef

53.

Quirk BJ, Brandal G, Donlon S et al (2015) Photodynamic therapy (PDT) for malignant brain tumors—where do we stand? Photodiagnosis Photodyn Ther 12(3):530–544PubMedCrossRef

54.

Kaneko S, Fujimoto S, Yamaguchi H et al (2018) Photodynamic therapy of malignant gliomas. Prog Neurol Surg 32(1):13

55.

Jain KKA (2018) critical overview of targeted therapies for glioblastoma. Front Oncol 8:419PubMedPubMedCentralCrossRef

56.

Scott JN, Rewcastle NB, Brasher PM et al (1998) Long-term glioblastoma multiforme survivors: a population-based study. Can J Neurol Sci 25(3):197–201PubMedCrossRef

57.

Figge FH, Weiland GS, Manganiello LO (1948) Cancer detection and therapy; affinity of neoplastic, embryonic, and traumatized tissues for porphyrins and metalloporphyrins. Proc Soc Exp Biol Med 68(3):640PubMedCrossRef

58.

Rassmussen-Taxdal DS, Ward GE, Figge FH (1955) Fluorescence of human lymphatic and cancer tissues following high doses of intravenous hematoporphyrin. Cancer 8(1):78–81PubMedCrossRef

59.

Yang J, Shi Z, Liu R et al (2020) Combined-therapeutic strategies synergistically potentiate glioblastoma multiforme treatment via nanotechnology. Theranostics 10(7):3223–3239PubMedPubMedCentralCrossRef

60.

Kessel D (2019) Photodynamic therapy: a brief history. J Clin Med 8(10):1581PubMedCentralCrossRef

61.

Lieberman FS, Wang M, Robins HI et al (2019) Phase 2 study of radiation therapy plus low-dose temozolomide followed by temozolomide and irinotecan for glioblastoma: NRG Oncology RTOG Trial 0420. Int J Radiat Oncol Biol Phys 103(4):878–886PubMedCrossRef

62.

Bruhn H, Strandéus M, Milos P et al (2018) Improved survival of Swedish glioblastoma patients treated according to Stupp. Acta Neurol Scand 138(4):332–337PubMedCrossRef

63.

Warren KT, Liu L, Liu Y et al (2019) The impact of timing of concurrent chemoradiation in patients with high-grade glioma in the era of the Stupp protocol. Front Oncol 9:186PubMedPubMedCentralCrossRef

Titel: A systematic review and meta-analysis of fluorescent-guided resection and therapy-based photodynamics on the survival of patients with glioma
verfasst von: Zhongyu Ren
Jun Wen
Yunyan Mo
Peng Zhang
Hanren Chen
Jian Wen
Publikationsdatum: 28.09.2021
Verlag: Springer London
Erschienen in: Lasers in Medical Science / Ausgabe 2/2022
Print ISSN: 0268-8921
Elektronische ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-021-03426-7

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

A systematic review and meta-analysis of fluorescent-guided resection and therapy-based photodynamics on the survival of patients with glioma

Abstract

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2022

High-frequency near-infrared diode laser irradiation suppresses IL-1β-induced inflammatory cytokine expression and NF-κB signaling pathways in human primary chondrocytes

Combination of cisplatin treatment and photodynamic therapy attenuates cisplatin-induced cell toxicity in A2780 and A2780-CP cervical cancer cell lines

Photoacoustic detection of ammonia exhaled by individuals with chronic kidney disease

Detection of hypokalemia disorder and its relation with hypercalcemia in blood serum using LIBS technique for patients of colorectal cancer grade I and grade II

Probing depth reduction of laser application in periodontal therapy: a network meta-analysis

Clinical effectiveness of adjunctive diode laser on scaling and root planing in the treatment of periodontitis: is there an optimal combination of usage mode and application regimen? A systematic review and meta-analysis